Semaglutide supports sustainable weight loss and overall health by targeting GLP-1 receptors, which help control appetite and improve insulin sensitivity. This means you feel fuller for longer, eat fewer calories, and experience reduced cravings, making weight management easier. It also slows digestion, keeping you satisfied after meals and helping prevent overeating.
Beyond weight loss, semaglutide has positive effects on metabolic health, including better blood sugar control, improved cholesterol levels, and potential heart health benefits. Research suggests that with continued use, weight regain is minimal, supporting long-term success. Additionally, semaglutide may naturally shift food preferences toward healthier, lower-fat options, reinforcing better eating habits. When used consistently, it offers a comprehensive approach to weight loss and overall well-being.
Further Reading:
1. Ard, J., et al. (2021). Weight Loss and Maintenance Related to the Mechanism of Action of Glucagon-like Peptide 1 Receptor Agonists. Advances in Therapy, 38(6), 2821-2839. https://doi.org/10.1007/s12325-021-01710-0
2. Ghusn, W., et al. (2022). Weight Loss Outcomes Associated with Semaglutide Treatment for Patients with Overweight or Obesity. JAMA Network Open, 5(9), e2231982. https://doi.org/10.1001/jamanetworkopen.2022.31982
3. Smits, M.M., & Van Raalte, D.H. (2021). Safety of Semaglutide. Frontiers in Endocrinology, 12, 645563. https://doi.org/10.3389/fendo.2021.645563
4. Alorfi, N.M., & Algarni, A.S. (2022). Clinical Impact of Semaglutide, a Glucagon-like Peptide-1 Receptor Agonist, on Obesity Management: A Review. Clinical Pharmacology: Advances and Applications, 14, 61-67. https://doi.org/10.2147/cpaa.s374741
5. Wilding, J.P.H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine, 384(11), 989-1002. https://doi.org/10.1056/NEJMoa2032183
6. Garvey, W.T., et al. (2022). Two-Year Effects of Semaglutide in Adults with Overweight or Obesity: The STEP 5 Trial. Nature Medicine, 28(10), 2083-2091. https://doi.org/10.1038/s41591-022-02026-4
7. Anam, M., et al. (2022). "Efficacy of Semaglutide in Treating Obesity: A Systematic Review of Randomized Controlled Trials (RCTs)." Cureus, vol. 14, no. 12, e32610. https://doi.org/10.7759/cureus.32610